Keyphrases
Omega-3 Fatty Acids
100%
Randomized Controlled Trial
100%
Omega-3
100%
Symptomatic Atrial Fibrillation
100%
Placebo
80%
Confidence Interval
60%
Placebo Groups
60%
Hazard Ratio
60%
Paroxysmal Atrial Fibrillation
60%
Atrial Fibrillation
60%
Adverse Events
40%
Treatment Options
40%
Persistent Atrial Fibrillation
40%
Paroxysmal
40%
First Recurrence
40%
Blood Levels
20%
Treatment Group
20%
Effective Treatment
20%
Symptom Recurrence
20%
Prospective Randomized Trial
20%
Randomized Double-blind
20%
Unmet Medical Need
20%
Placebo-controlled
20%
Multicenter Trial
20%
Trial Registration
20%
Omega-3 Polyunsaturated Fatty Acids
20%
Normal Sinus Rhythm
20%
Additional Treatment
20%
Pharmacological Treatment
20%
Structural Heart Disease
20%
Atrial Fibrillation Recurrence
20%
Eicosapentaenoic and Docosahexaenoic Acids
20%
Pharmacology, Toxicology and Pharmaceutical Science
Omega-3 Fatty Acid
100%
Randomized Controlled Trial
100%
Atrial Fibrillation
100%
Placebo
80%
Recurrent Disease
40%
Paroxysmal Atrial Fibrillation
30%
Adverse Event
20%
Heart Atrium Flutter
20%
Heart Disease
10%
Docosahexaenoic Acid
10%
Icosapentaenoic Acid
10%
Persistent Atrial Fibrillation
10%
Treatment Group
10%
Neuroscience
Randomized Controlled Trial
100%
Omega 3 Fatty Acid
100%
Atrial Fibrillation
100%
Placebo
57%
Docosahexaenoic Acid
7%
Icosapentaenoic Acid
7%
Food Science
Omega 3 Fatty Acid
100%
Polyunsaturated Fatty Acid
12%